Evidence map›Paper›PMID 29017757›Full record

ArticleExperimental cell research2017

Effects of retinoic acid signaling on extraocular muscle myogenic precursor cells in vitro.

Sadie L Hebert, Krysta R Fitzpatrick, Samantha A McConnell, Anja Cucak, Ching Yuan, Linda K McLoon

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Branchiomeric Muscle Development Requires Proper Retinoic Acid Signaling.Frontiers in cell and developmental biology · 2021
    Article
  4. Article
  5. The Ocular Neural Crest: Specification, Migration, and Then What?Frontiers in cell and developmental biology · 2020
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sadie L HebertDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, United States.
Krysta R FitzpatrickDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, United States.
Samantha A McConnellDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, United States.
Anja CucakDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, United States.
Ching YuanDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, United States.
Linda K McLoonDepartment of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, United States; Department of Neuroscience, University of Minnesota, Minneapolis, MN, United States. Electronic address: mcloo001@umn.edu.
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI MAUREEN E NEITZ · 1985 to 2026
$23.5M
MINNESOTA PAIN RESEARCH TRAINING PROGRAMT32DE007288 · NIDCR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERZBERG, MARK C · 1996 to 2011
$8.8M
Visual TestingP30EY011374 · NEI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NEWMAN, ERIC A · 1996 to 2019
$8.8M
Use of specific transcription factors to promote limb regeneration capacityP30AR057220 · NIAMS · UNIVERSITY OF MINNESOTA · PI KARACHUNSKI, PETER ISAAK · 2009 to 2013
$3.0M
Myogenic Potential of Extraocular Muscle Satellite CellsR21EY019620 · NEI · UNIVERSITY OF MINNESOTA · PI MCLOON, LINDA K. · 2009 to 2010
$376k
NCI NIH HHS P30 CA077598NEI NIH HHS EY55137NEI NIH HHS P30 EY001730NEI NIH HHS P30 EY011374NEI NIH HHS P30 EY11375NEI NIH HHS R21 EY019620NIAMS NIH HHS P30 AR057220NIDCR NIH HHS T32 DE007288
6 · The paper itself

Abstract

One major difference between limb and extraocular muscles (EOM) is the presence of an enriched population of Pitx2-positive myogenic precursor cells in EOM compared to limb muscle. We hypothesize that retinoic acid regulates Pitx2 expression in EOM myogenic precursor cells and that its effects would differ in leg muscle. The two muscle groups expressed differential retinoic acid receptor (RAR) and retinoid X receptor (RXR) levels. RXR co-localized with the Pitx2-positive cells but not with those expressing Pax7. EOM-derived and LEG-derived EECD34 cells were treated with vehicle, retinoic acid, the RXR agonist bexarotene, the RAR inverse agonist BMS493, or the RXR antagonist UVI 3003. In vitro, fewer EOM-derived EECD34 cells expressed desmin and fused, while more LEG-derived cells expressed desmin and fused when treated with retinoic acid compared to vehicle. Both EOM and LEG-derived EECD34 cells exposed to retinoic acid showed a higher percentage of cells expressing Pitx2 compared to vehicle, supporting the hypothesis that retinoic acid plays a role in maintaining Pitx2 expression. We hypothesize that retinoic acid signaling aids in the maintenance of large numbers of undifferentiated myogenic precursor cells in the EOM, which would be required to maintain EOM normalcy throughout a lifetime of myonuclear turnover.

Indexed as

AnimalsApoptosisCell ProliferationCells, CulturedHomeobox Protein PITX2Homeodomain ProteinsIn Vitro TechniquesKeratolytic AgentsMiceMice, Inbred C57BLMuscle DevelopmentMuscle, SkeletalMyoblastsOculomotor MusclesPAX7 Transcription FactorRetinoid X ReceptorsHomeobox Protein PITX2Homeodomain ProteinsKeratolytic AgentsPax7 protein, mousePAX7 Transcription FactorRetinoid X ReceptorsTranscription FactorsTretinoinExtraocular muscleMuscle stem cellsRetinoic acidRetinoic acid signaling

Identifiers

PMID29017757
PMCPMC6546114
OpenAlexW2764155988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.